Cardiogenomics Registry

Piedmont Healthcare2,601 enrolled

Overview

This is a continuous blood banking study that will archive plasma and blood permitting DNA and plasma analysis at a future date. Subjects are recruited at the time of a clinically required procedure and blood samples are collected and banked and used for future research. The main purpose of this study is to investigate the interaction of multiple phenotypes and genotypes and their impact on cardiovascular disease events and measures of atherosclerosis progression.

Study Type

OBSERVATIONAL

Enrollment

2,601

Conditions

Cardiovascular Disease

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * \> 17 years of age * Undergoing a clinical required cardiovascular procedure * Agree to donation of blood sample * Provide written informed consent and Authorization for Use/Disclosure of PHI Exclusion Criteria: * \< 18 years of age * Refusal to donate a blood sample * Refusal to provide written informed consent and Authorization for Use/Disclosure of PHI

Locations (1)

Piedmont Hospital

Atlanta, Georgia, United States

Outcomes

Primary Outcomes

To assess the relationship of multiple phenotypes and genotypes with cardiovascular disease

Time frame: Yearly

Secondary Outcomes

To assess the impact of phenotypes and genotypes of specific patient subgroups (gender, ethnic, family history) on cardiovascular disease

Time frame: Yearly

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.